萨尔科佩尼亚轨迹预测可手术头癌的生存率
Marco A Mascarella1,2,3, Alex Mlynarek2, Keith Richardson2
1Department of Biomedical Sciences, Université de Montréal, Montreal, Quebec, Canada.
Head & neck
|June 10, 2025
概括
萨科佩尼亚轨迹预测了头癌的结果. 患者仍然或进展到肉症面临更糟糕的生存率,突出其作为一个动态生物标志物的作用.
科学领域:
- 在瘤学瘤学.
- 老年病的医生 老年病的医生
- 身体组成分析 身体成分分析
背景情况:
- 萨科佩尼亚与头部和部状细胞癌 (HNSCC) 的较差结果和增加的毒性有关.
- 了解肉症的动态变化对于预测可操作的HNSCC患者的预后至关重要.
研究的目的:
- 为了评估可手术的HNSCC患者的肉症轨迹.
- 评估这些轨迹与整体存活率 (OS) 和无病存活率 (DFS) 之间的关联.
主要方法:
- 在接受手术的332名II-IV期HPV阴性HNSCC患者的治疗前和后分析了身体成分.
- 萨科佩尼亚轨迹被分为四组:仍然是萨科佩尼亚,仍然是非萨科佩尼亚,从萨科佩尼亚恢复,或进展为萨科佩尼亚.
- 用多重考克斯回归来分析生存结果.
主要成果:
- 108名患者在基线时患有肉,治疗后仍有106名患者患有肉.
- 与那些保持非sarcopenic的患者相比,那些仍然是sarcopenic或进展为sarcopenia的患者的OS和DFS明显更差.
- 对生存分析中的混因素进行了调整.
结论:
- 在可操作的HNSCC中,sarcopenia轨迹作为动态生物标志物.
- 这些在肉症的动态变化可以预测瘤的结果,包括生存.
相关概念视频
Cancer Survival Analysis
650
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
650
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Rous Sarcoma Virus (RSV) and Cancer
6.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.2K
Adaptive Mechanisms in Cancer Cells
7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K


